Mineralocorticoid Receptor Antagonism by Finerenone Attenuates Established Pulmonary Hypertension in Rats

ABSTRACT: We studied the ability of the non-steroidal Mineralocorticoid Receptor (MR) antagonist finerenone to attenuate vascular remodeling and pulmonary hypertension (PH) using two complementary preclinical models [the monocrotaline (MCT) and Sugen

ORGANISM(S): Homo sapiens

PROVIDER: GSE202698 | GEO | 2025/05/11

REPOSITORIES: GEO